ZELTIQ Aesthetics (ZLTQ) Adds Two Aesthetic Device Vets to Payroll
Tweet
Share
E-mailGet Alerts ZLTQ Hot Sheet
Join SI Premium – FREE
ZELTIQ Aesthetics, Inc. (Nasdaq: ZLTQ) announced that it has strengthened its management team with the addition of two aesthetic device industry veterans. Effective immediately, Len DeBenedictis has joined the Company as Chief Technology Officer and Keith J. Sullivan has joined as Senior Vice President of Worldwide Sales.
Mr. DeBenedictis, who has more than 35 years of experience as an inventor and executive in the medical device and technology industries, will lead the Company's R&D efforts as Chief Technology Officer, focusing on continued innovation and new product development. Mr. Sullivan, who has more than 30 years of experience in the medical device industry, will assume the role of SVP of Worldwide Sales, to better align and strengthen the Company's global sales efforts.
Mr. DeBenedictis has 35 years of experience as a high technology pioneer, inventor and senior executive in the medical device and aesthetics industries. Most recently, Mr. DeBenedictis served as CTO of Cutera Inc, a leading provider of laser and other light-based aesthetic systems, where he led the R&D efforts. Previously, Mr. DeBenedictis served as CTO and Board Member of Solta Medical, a global provider of aesthetic treatments. Prior to Solta, Mr. DeBenedictis served as Co-Founder and Board Member of Reliant Technologies, where he conceived, developed and named the Fraxel Brand skin resurfacing products. Earlier in his career, Mr. DeBenedictis served in various executive and scientific roles at Coherent Medical Group, Spectra Physics Construction Systems, Atlantic Richfield, Xerox and Korad Lasers.
Mr. Sullivan has more than 30 years of sales experience in the medical device industry. Most recently, Mr. Sullivan served as SVP of Commercial Operations of Medicis Technology, a division of Medicis Pharmaceuticals, Inc. While at Medicis, Mr. Sullivan was responsible for developing and implementing the global sales and marketing strategy for LipoSonix, a High Intensity Focused Ultrasound (HIFU) device that subcutaneously treats unwanted fat. Mr. Sullivan later led the Medicis divestiture team, orchestrating the sale of Liposonix to Solta in November 2011. Prior to Medicis, Mr. Sullivan served as VP of Global Sales and Channel Marketing of Reliant Technologies, where he was one of five officers responsible for all strategic decisions for Reliant and helped to develop the company's recurring revenue model. Earlier in his career, Mr. Sullivan held sales positions of increasing responsibility at companies such as Medtronic, Vision Quest Laser, Coherent Medical and American V. Mueller, a division of American Hospital Supply.
Mr. DeBenedictis, who has more than 35 years of experience as an inventor and executive in the medical device and technology industries, will lead the Company's R&D efforts as Chief Technology Officer, focusing on continued innovation and new product development. Mr. Sullivan, who has more than 30 years of experience in the medical device industry, will assume the role of SVP of Worldwide Sales, to better align and strengthen the Company's global sales efforts.
Mr. DeBenedictis has 35 years of experience as a high technology pioneer, inventor and senior executive in the medical device and aesthetics industries. Most recently, Mr. DeBenedictis served as CTO of Cutera Inc, a leading provider of laser and other light-based aesthetic systems, where he led the R&D efforts. Previously, Mr. DeBenedictis served as CTO and Board Member of Solta Medical, a global provider of aesthetic treatments. Prior to Solta, Mr. DeBenedictis served as Co-Founder and Board Member of Reliant Technologies, where he conceived, developed and named the Fraxel Brand skin resurfacing products. Earlier in his career, Mr. DeBenedictis served in various executive and scientific roles at Coherent Medical Group, Spectra Physics Construction Systems, Atlantic Richfield, Xerox and Korad Lasers.
Mr. Sullivan has more than 30 years of sales experience in the medical device industry. Most recently, Mr. Sullivan served as SVP of Commercial Operations of Medicis Technology, a division of Medicis Pharmaceuticals, Inc. While at Medicis, Mr. Sullivan was responsible for developing and implementing the global sales and marketing strategy for LipoSonix, a High Intensity Focused Ultrasound (HIFU) device that subcutaneously treats unwanted fat. Mr. Sullivan later led the Medicis divestiture team, orchestrating the sale of Liposonix to Solta in November 2011. Prior to Medicis, Mr. Sullivan served as VP of Global Sales and Channel Marketing of Reliant Technologies, where he was one of five officers responsible for all strategic decisions for Reliant and helped to develop the company's recurring revenue model. Earlier in his career, Mr. Sullivan held sales positions of increasing responsibility at companies such as Medtronic, Vision Quest Laser, Coherent Medical and American V. Mueller, a division of American Hospital Supply.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Veeva Systems names Dan Rizzo EVP of sales amid leadership change
- Albemarle names Max Hood as chief accounting officer
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
